The authors respond to: Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: effect on resource utilization.

Abstract

The article by Kallam and colleagues1 about the potential financial advantages of protocol-driven bronchodilator therapy provides an important perspective. However, there are no data about the validation of the scoring tool or the evidence supporting the correlation of the bronchodilator orders with the assessment score. While we await their report on their before-and-after project examining clinical outcomes, can they provide this missing information?

DOI: 10.4187/respcare.02502

Cite this paper

@article{Kallam2013TheAR, title={The authors respond to: Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: effect on resource utilization.}, author={Avyakta Kallam and Ariel M . Modrykamien}, journal={Respiratory care}, year={2013}, volume={58 7}, pages={e83} }